TEM Tempus AI, Inc.
$76.61▲ +6.18%
Healthcare
Other
Volume 6.87M
Avg Volume (10D) 5.19M
Key Metrics & Fundamentals
Market Cap
$13.96B
P/E Ratio
–
Div Yield
0.00%
52W Range
40.77 - 91.83
% vs 50 MA
9.06%
% vs 200 MA
34.71%
RSI-14
58.7
MACD Histogram
+0.3100
Beta (1Y vs SPY)
2.58
Free Cash Flow
-$18.62M
Gross Rev
$382.49M
Gross Profit
$246.50M
EBITDA
$56.73M
COGS
$135.99M
Operating Exp
$322.41M
Operating Income
-$75.91M
EBIT
-$75.91M
Pretax Income
$8.82M
Net Income
$5.64M
EPS (Diluted)
0.03
Price & Volume History
Loading chart…
Recent News
IPO Edge NYSE Firesides Scheduled for Dec 7
IPO-Edge.com · Oct 28, 2026 6:21 PM ET
Absci Soars 12%, Schrödinger Up 11%, Recursion Up 9% as AI Drug Discovery Stocks Rally
TIKR · Oct 28, 2026 12:11 PM ET
Earnings Preview: Schrodinger, Inc. (SDGR) Q3 Earnings Expected to Decline
Zacks · Oct 28, 2026 9:00 AM ET
Can You Still Buy Tempus AI Stock Today?
Trefis · Oct 28, 2026 7:56 AM ET
Tempus AI (TEM) Could Be 5% Undervalued After Bristol Myers And Pathos Deals
Simply Wall St. · Oct 27, 2026 6:08 PM ET
The $1.5 Billion Question Facing Tempus AI Ahead of Nov. 2 Earnings
24/7 Wall St. · Oct 27, 2026 9:28 AM ET
Tempus AI Receives EU Certification for xR RNA Sequencing
MT Newswires · Oct 26, 2026 9:56 AM ET
Tempus AI (TEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks · Oct 26, 2026 9:00 AM ET
What Happens To Tempus AI Stock If Its Cash Burn Continues?
Trefis · Oct 26, 2026 8:47 AM ET
Tempus Receives IVDR Certification for xR RNA Sequencing for Solid Tumor Profiling
Business Wire · Oct 26, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TEM's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.